Amla therapy as a potential modulator of Alzheimer's disease risk factors and physiological change

Elham Teimouri, Stephanie R. Rainey-Smith, Prashant Bharadwaj, Giuseppe Verdile, Ralph N. Martins*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    2 Citations (Scopus)

    Abstract

    There is currently no effective treatment for Alzheimer's disease (AD), the most common form of dementia. It has been proposed, however, that a modest delay in onset can significantly reduce the number of cases. Thus, prevention and intervention strategies are currently the focus of much research. In the search for compounds that potentially confer benefit, the Amla fruit and its extracts have drawn attention. Amla preparations have been used for centuries in traditional Indian medicine systems such as Ayurveda, with various parts of the plant used to treat a variety of diseases. Here we review many animal-based studies, and some clinical trials, which have shown that Amla, and its extracts, exert many positive effects on dyslipidemia, hyperglycemia, inflammation, oxidative stress, apoptosis, and autophagy, that contribute to AD risk. Collectively, this evidence suggests that Amla may be of value as part of an effective disease-delaying treatment for AD.

    Original languageEnglish
    Pages (from-to)713-733
    Number of pages21
    JournalJournal of Alzheimer's Disease
    Volume74
    Issue number3
    DOIs
    Publication statusPublished - 2020

    Keywords

    • Alzheimer's disease
    • Amla
    • anti-inflammatory
    • antioxidant
    • cardiovascular disease
    • type 2 diabetes

    Fingerprint

    Dive into the research topics of 'Amla therapy as a potential modulator of Alzheimer's disease risk factors and physiological change'. Together they form a unique fingerprint.

    Cite this